[1]
|
Armstrong, K. and Weinstein, M. (2011) Pyogenic Granulomas during Isotretinoin Therapy. Journal of Dermatological Case Reports, 5, 5-7. https://doi.org/10.3315/jdcr.2011.1062
|
[2]
|
Lin, R.L. and Janniger, C.K. (2004) Pyogenic Granuloma. Cutis, 74, 229-233.
|
[3]
|
Ghodsi, S.Z., Raziei, M., Taheri, A., Karami, M., Mansoori A. and Farnaghi, F. (2006) Comparison of Cryotherapy and Curettage for the Treatment of Pyogenic Granuloma: A Randomized Trial. British Journal of Dermatology, 154, 671-675.
|
[4]
|
Lee, J., Sinno, H., Tahiri, Y. and Gilardino, M.S. (2011) Treatment Options for Cutaneous Pyogenic Granulomas: A Review. Journal of Plastic, Reconstructive & Aesthetic Surgery, 64, 1216-1220. https://doi.org/10.1016/j.bjps.2010.12.021
|
[5]
|
Bilu, D. and Sauder, D.N. (2003) Imiquimod: Modes of Action. British Journal of Dermatology, 149 (Suppl. 66), 5-8.
|
[6]
|
Schön, M.P. and Schön, M. (2004) Immune Modulation and Apoptosis Induction: Two Sides of the Antitumoral Activity of Imiquimod. Apoptosis, 9, 291-298. https://doi.org/10.1023/B:APPT.0000025805.55340.c3
|
[7]
|
Pasmatzi, E., Chaidaroglou, A., Sakkis, T., Monastirli, A., Georgiou, S., Sagriotis, A., Matsouka, P., Degiannis, D. and Tsambaos, D. (2009) Topical Application of Imiquimod Induces Alterations in Peripheral Blood Lymphocytes in Healthy Individuals. Acta Dermato-Venereologica, 89, 134-139.
|
[8]
|
Urosevic, M., Oberholzer, P.A., Maier, T., Hafner, J., Laine, E. and Slade, H. (2004) Imiquimod Treatment Induced Expression of Opioid Growth Factor Receptor: A Novel Tumor Antigen Induced by Interferon-Alpha. Clinical Cancer Research, 10, 4959-4970. https://doi.org/10.1158/1078-0432.CCR-04-0193
|
[9]
|
Hennge, U.R. and Ruzicka, T. (2004) Topical Immunomodulation in Dermatology: Potential of Toll-Like Receptor Agonists. Dermatologic Surgery, 30, 1101-1112. https://doi.org/10.1097/00042728-200408000-00008
|
[10]
|
Badavanis, G., Monastirli, A., Pasmatzi, E. and Tsambaos, D. (2005) Successful treatment of Granuloma Annulare with Imiquimod Cream 5%: A Report of Four Cases. Acta Dermato-Venereologica, 85, 547-548.
|
[11]
|
Tsambaos, D., Chaidaroglou, A, Sakkis, Th., Sagriotis, A., Georgiou, S., Badavanis G., Pasmatzi, E., Monastirli, A., Matsouka P. and Degiannis, D. (2006) Topical Toll-Like Receptor Agonists: A New Era in Cutaneous Immunotherapy. Review of Clinical Pharmacology and Pharmacokinetics, 20, 341-343.
|
[12]
|
Georgiou, S., Monastirli, A, Pasmatzi, E. and Tsambaos, D. (2008) Pyogenic Granuloma: Complete Remission under Occlusive Imiquimod 5% Cream. Clinical and Experimental Dermatology, 33, 454-456. https://doi.org/10.1111/j.1365-2230.2007.02677.x
|
[13]
|
Monastirli, A., Melachrinou, M., Pasmatzi, E., Georgiou, S. and Tsambaos, D. (2010) Successful Treatment of Lichen Striatus with Occlusive Imiquimod 5% Cream. Hospital Chronicles, 5, 33-35.
|
[14]
|
Tsambaos, D., Rodi, M., Pasmatzi, E., Monastirli, A., Papadaki, H. and Mouzaki, A. (2011) Long-Term Remission οf Recurrent Herpes Labialis Following Topical Imiquimod Application on Distal Healthy Skin: A Clinical and Immunological Study. Antiviral Therapy, 16, 863-869. https://doi.org/10.3851/IMP1793
|
[15]
|
Badavanis, G., Pasmatzi, E., Monastirli, A., Georgiou, S. and Tsambaos, D. (2017) Topical Imiquimod Is an Effective and Safe Drug for Molluscum Contagiosum in Children. Acta Dermatovenerologica Croatica, 25, 165-166.
|
[16]
|
Yuan, K., Jin, Y.T. and Lin, M.T. (2000) The Detection and Comparison of Angiogenesis-Associated Factors in Pyogenic Granuloma by Immunohistochemistry. Journal of Periodontology, 71, 701-709. https://doi.org/10.1902/jop.2000.71.5.701
|
[17]
|
Nelimarkka, L., Salminen, H., Kuopio, T., Nikkari, S., Ekfors, T. and Laine, J. (2001) Decorin Is Produced by Capillary Endothelial Cells in Inflammation-Associated Angiogenesis. American Journal of Pathology, 158, 345-353. https://doi.org/10.1016/S0002-9440(10)63975-2
|
[18]
|
Godfraind, C., Calicchio, M.L. and Kozakewich, H. (2013) Pyogenic Granuloma, an Impaired Wound Healing Process, Linked to Vascular Growth Driven by FLT4 and the Nitric Oxide Pathway. Modern Pathology, 26, 247-255. https://doi.org/10.1038/modpathol.2012.148
|
[19]
|
Hesling, C., D'Incan, M., Mansard, S., Franck, F., Corbin-Duval, A. and Chèvenet, C. (2004) In Vivo and in Situ Modulation of the Expression of Genes Involved in Metastasis and Angiogenesis in a Patient Treated with Topical Imiquimod for Melanoma Skin Metastases. British Journal of Dermatology, 150, 761-767. https://doi.org/10.1111/j.0007-0963.2004.05898.x
|
[20]
|
Li, V.W., Li, W.W., Talcott, K.E. and Zhai, A.W. (2005) Imiquimod as an Antiangiogenic Agent. Journal of Drugs in Dermatology, 4, 708-717.
|
[21]
|
Fallah, H., Fischer, G. and Zagarella, S. (2007) Pyogenic Granuloma in Children: Treatment with Topical Imiquimod. Australasian Journal of Dermatology, 48, 217-220. https://doi.org/10.1111/j.1440-0960.2007.00389.x
|
[22]
|
Tritton, S.M., Smith, S., Wong, L.C., Zagarella, S. and Fischer, G. (2009) Pyogenic Granuloma in Ten Children Treated with Topical Imiquimod. Pediatric Dermatology, 26, 269-272. https://doi.org/10.1111/j.1525-1470.2008.00864.x
|
[23]
|
Gencoglan, G., Inanir, I. and Gündüz, K. (2009) Pyogenic Granuloma in Two Children Successfully Treated with Imiquimod 5% Cream. Pediatric Dermatology, 26, 366-368. https://doi.org/10.1111/j.1525-1470.2009.00927.x
|
[24]
|
Mao, X.H., Wang, J.Y. and Yan, J.L. (2009) Topical Imiquimod Treatment of Cutaneous Vascular Disorders in Pediatric Patients: Clinical Evaluation on the Efficacy and Safety. Journal of Zhejiang University. Science B, 13, 745-750. https://doi.org/10.1631/jzus.B1200120
|
[25]
|
Musumeci, M.L., Lacarrubba, F., Anfuso, R., Li Calzi, M. and Micali, G. (2013) Two Pediatric Cases of Pyogenic Granuloma Treated with Imiquimod 5% Cream: Combined Clinical and Dermatoscopic Evaluation and Review of the Literature. Giornale Italiano di Dermatologia e Venereologia, 148, 147-152.
|